Sumitomo Chemi.

  • Market Cap: Small Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE258G01013
  • NSEID: SUMICHEM
  • BSEID: 542920
INR
407.10
5.5 (1.37%)
BSENSE

Jan 29

BSE+NSE Vol: 5.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.51 lacs (-26.94%) Volume

Shareholding (Dec 2025)

FII

3.37%

Held by 113 FIIs

DII

1.17%

Held by 21 DIIs

Promoter

75.00%

What does Sumitomo Chemi. do?

06-Jun-2025

Sumitomo Chemical India Ltd manufactures household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products. As of March 2025, it reported net sales of ₹679 Cr and a net profit of ₹100 Cr, with a market cap of ₹25,853 Cr.

Overview: <BR>Sumitomo Chemical India Ltd is engaged in the manufacturing of household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products, operating within the Pesticides & Agrochemicals industry and classified as a Large Cap company.<BR><BR>History: <BR>Sumitomo Chemical India Ltd was incorporated on 15 February 2000 and transitioned from Private Limited to Public Limited status on 24 November 2018. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 679 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 100 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 25,853 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 51.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.17% <BR>Debt-Equity: -0.15 <BR>Return on Equity: 17.42% <BR>Price to Book: 8.90 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

View full answer

Who are in the management team of Sumitomo Chemi.?

06-Jun-2025

As of March 2022, the management team of Sumitomo Chemi includes Mukul G Asher (Chairman), Chetan Shah (Managing Director), and several directors and officers responsible for the company's operations and strategy.

As of March 2022, the management team of Sumitomo Chemi includes the following individuals:<BR><BR>1. Mukul G Asher - Chairman & Independent Director<BR>2. Chetan Shah - Managing Director<BR>3. B V Bhargava - Independent Director<BR>4. Ninad D Gupta - Director<BR>5. Preeti Mehta - Independent Director<BR>6. Sushil Marfatia - Executive Director<BR>7. Masanori Uzawa - Director<BR>8. Suresh Ramachandran - Whole-time Director<BR>9. Deepika Trivedi - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

View full answer

When is the next results date for Sumitomo Chemi.?

06-Jun-2025

No Upcoming Board Meetings

Has Sumitomo Chemi. declared dividend?

06-Jun-2025

Yes, Sumitomo Chemical India Ltd has declared a 9% dividend (₹0.9 per share) with an ex-date of July 19, 2024. While recent performance shows mixed returns, the company has demonstrated positive growth over the longer term, especially with a total return of 92.31% over the past five years.

Yes, Sumitomo Chemical India Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 9%<BR>- Amount per share: 0.9<BR>- Ex-date: 19 Jul 24<BR><BR>Dividend Yield: 0.17%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -6.03%, with a dividend return of 0%, resulting in a total return of -6.03%.<BR><BR>For the 1-year period, the price return was 8.21%, the dividend return was 0.18%, leading to a total return of 8.39%.<BR><BR>Over the 2-year period, the price return was 25.17%, the dividend return was 1.66%, resulting in a total return of 26.83%.<BR><BR>In the 3-year period, the price return was 7.24%, the dividend return was 1.98%, culminating in a total return of 9.22%.<BR><BR>During the 4-year period, the price return was 45.11%, with a dividend return of 2.30%, giving a total return of 47.41%.<BR><BR>For the 5-year period, the price return was 88.86%, the dividend return was 3.45%, resulting in a total return of 92.31%.<BR><BR>Overall, Sumitomo Chemical India Ltd has declared a dividend, and while the recent performance shows mixed returns, the longer-term trends indicate positive growth, particularly over the 5-year period.

View full answer

Who are the peers of the Sumitomo Chemi.?

03-Jun-2025

Sumitomo Chemi.'s peers include P I Industries, UPL, Bayer CropSci., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries. Dhanuka Agritech shows the highest growth and return, while Bharat Rasayan has the lowest return, with Sumitomo Chemi. achieving an 8.51% return.

Peers: The peers of Sumitomo Chemi. are P I Industries, UPL, Bayer CropSci., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci. and Dhanuka Agritech, while Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, and the rest have Average management risk. Growth is Excellent at Dhanuka Agritech, while Excellent capital structure is noted for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, and Bharat Rasayan, with the rest showing Below Average growth and Below Average capital structure.<BR><BR>Return Snapshot: Dhanuka Agritech has the highest 1-year return at 32.65%, while Bharat Rasayan has the lowest at -12.17%, with Sumitomo Chemi.'s 1-year return at 8.51% being higher than Bharat Rasayan's but lower than Dhanuka Agritech's. Additionally, UPL, Bhagiradha Chem., Bharat Rasayan, and NACL Industries have negative six-month returns.

View full answer

Is Sumitomo Chemi. overvalued or undervalued?

09-Jun-2025

As of February 14, 2020, Sumitomo Chemical India Ltd. is considered very expensive and overvalued, with a PE ratio of 51.25 and a Price to Book Value of 8.93, despite a strong ROCE of 23.07%, indicating it trades at a premium compared to its peers and has underperformed in longer-term returns.

As of 14 February 2020, the valuation grade for Sumitomo Chemical India Ltd. has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 51.25, a Price to Book Value of 8.93, and an EV to EBITDA of 40.28, all of which suggest that the stock is trading at a premium compared to its earnings and asset values.<BR><BR>In comparison to its peers, Sumitomo Chemical India Ltd. stands out with a PE ratio of 51.25, while its closest competitor has a lower valuation, reinforcing its overvalued status. Additionally, the company's return on capital employed (ROCE) is a strong 23.07%, but this does not offset the high valuation metrics. Notably, while the stock has outperformed the Sensex over the past week and month, it has lagged behind in year-to-date and longer-term returns, further supporting the conclusion that it is overvalued in the current market context.

View full answer

Who are the top shareholders of the Sumitomo Chemi.?

17-Jul-2025

The top shareholders of Sumitomo Chemical include Sumitomo Chemical Co. Ltd. with 75.0%, mutual funds with 6.27%, foreign institutional investors at 3.63%, HSBC Small Cap Fund as the largest public shareholder at 1.09%, and individual investors holding 10.14%. This indicates a strong promoter presence in the company.

The top shareholders of Sumitomo Chemical include the following:<BR><BR>1. **Promoter with the highest holding**: Sumitomo Chemical Co. Ltd., which holds 75.0% of the shares.<BR>2. **Mutual Funds**: A total of 30 schemes collectively hold 6.27%.<BR>3. **Foreign Institutional Investors (FIIs)**: 131 FIIs hold 3.63%.<BR>4. **Highest Public Shareholder**: HSBC Small Cap Fund, with a holding of 1.09%.<BR>5. **Individual Investors**: They collectively hold 10.14% of the shares.<BR><BR>This distribution highlights a strong promoter presence in the company, particularly from Sumitomo Chemical Co. Ltd.

View full answer

How big is Sumitomo Chemi.?

24-Jul-2025

As of 24th July, Sumitomo Chemical India Ltd has a market capitalization of 29,450.00 Cr, with recent Net Sales of 3,148.53 Cr and a Net Profit of 505.50 Cr.

As of 24th July, Sumitomo Chemical India Ltd has a market capitalization of 29,450.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 3,148.53 Cr and a Net Profit of 505.50 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,901.14 Cr and Total Assets of 3,963.28 Cr.

View full answer

How has been the historical performance of Sumitomo Chemi.?

28-Oct-2025

Sumitomo Chemi experienced significant fluctuations in financial performance from March 2019 to March 2025, with net sales and operating income dropping to zero by March 2025, while maintaining a strong asset base and achieving profitability in profit before tax and profit after tax. Despite operational losses, total assets grew from 3,368.71 Cr to 3,963.28 Cr during this period.

Answer:<BR>The historical performance of Sumitomo Chemi shows significant fluctuations in key financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Sumitomo Chemi's net sales peaked at 3,510.97 Cr in March 2023 but dropped to 0.00 Cr by March 2025. The total operating income followed a similar trend, decreasing from 3,510.97 Cr in March 2023 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was 2,844.37 Cr in March 2023 and increased to 2,516.47 Cr in March 2025. Operating profit (PBDIT) showed a decline from 711.45 Cr in March 2023 to -2,516.47 Cr in March 2025, indicating a significant operational loss. Despite this, profit before tax improved from 654.18 Cr in March 2023 to 680.24 Cr in March 2025, while profit after tax also saw an increase from 502.21 Cr to 506.44 Cr in the same period. The company's total assets grew from 3,368.71 Cr in March 2023 to 3,963.28 Cr in March 2025, reflecting a strong asset base despite the operational challenges. Cash flow from operating activities decreased from 757.00 Cr in March 2024 to 452.00 Cr in March 2025, and the net cash outflow was recorded at -8.00 Cr in March 2025. Overall, while Sumitomo Chemi faced operational difficulties leading to losses, it maintained a solid asset position and managed to achieve profitability in terms of tax and net profit.

View full answer

Is Sumitomo Chemi. technically bullish or bearish?

17-Nov-2025

As of November 14, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the Sensex.

As of 14 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST and Dow Theory are also indicating bearish trends on the weekly, while the monthly signals are mildly bearish. The stock has underperformed significantly compared to the Sensex over various periods, further supporting the bearish outlook.

View full answer

Are Sumitomo Chemical India Ltd latest results good or bad?

27-Jan-2026

Sumitomo Chemical India Ltd's latest results are poor, with a 57.46% decline in net profit to ₹75.63 crore and a 38.92% drop in revenue to ₹567.98 crore compared to the previous quarter. The company faces significant margin compression and bearish stock indicators, suggesting caution for investors.

The latest results for Sumitomo Chemical India Ltd indicate a challenging quarter. In Q3 FY26, the company reported a net profit of ₹75.63 crore, which represents a significant decline of 57.46% compared to the previous quarter. Revenue also saw a sharp drop, falling to ₹567.98 crore, down 38.92% QoQ and 11.52% year-on-year. This decline marks the lowest quarterly revenue in the current fiscal year, highlighting the cyclical nature of the agrochemical business, particularly in the traditionally weaker Q3 period.<BR><BR>Additionally, both operating and profit after tax margins contracted considerably, with the operating margin decreasing to 17.52% from 23.45% in the previous quarter. This margin compression reflects pricing pressures and challenges in adjusting costs in line with the revenue decline.<BR><BR>Overall, the results can be characterized as poor, with significant declines in both profit and revenue, alongside deteriorating margins. The company's technical indicators also suggest a bearish trend, as the stock has been trading below key moving averages. Investors should be cautious, given these financial challenges and the elevated valuation multiples that may not be justified by the current growth trajectory.

View full answer

Should I buy, sell or hold Sumitomo Chemical India Ltd?

28-Jan-2026

Why is Sumitomo Chemical India Ltd falling/rising?

28-Jan-2026

As of 28-Jan, Sumitomo Chemical India Ltd's stock price is rising to Rs 404.00 after two days of decline, indicating a potential trend reversal. Despite this increase, the stock has underperformed over the past month and year, though heightened investor participation and a positive chemicals sector may be contributing to the current rise.

As of 28-Jan, Sumitomo Chemical India Ltd's stock price is rising, currently at Rs 404.00, reflecting a change of Rs 2.7 or 0.67%. This increase comes after two consecutive days of decline, indicating a potential trend reversal. The stock reached an intraday high of Rs 417.55, which is a 4.05% increase during the trading day. <BR><BR>Despite the current rise, the stock has been underperforming compared to the broader market, as evidenced by its negative returns over various periods, including a 12.58% decline over the past month and a 17.92% drop over the past year. Additionally, the stock is trading below its moving averages across multiple timeframes, suggesting a longer-term downward trend.<BR><BR>However, there are positive signs contributing to the current rise. Notably, there has been a significant increase in investor participation, with delivery volume on 27 January rising by 667.33% compared to the 5-day average. This heightened activity may indicate renewed interest from investors, despite the stock being close to its 52-week low, just 1.88% away from Rs 396.4. Furthermore, the chemicals sector as a whole has gained by 5.31%, which may also be positively influencing the stock's performance today.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 4.81% and Operating profit at 7.50% over the last 5 years

 
2

Negative results in Dec 25

3

With ROE of 17, it has a Very Expensive valuation with a 6.4 Price to Book Value

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 20,066 Cr (Small Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

39

stock-summary
Dividend Yield

0.30%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

16.97%

stock-summary
Price to Book

6.31

Revenue and Profits:
Net Sales:
568 Cr
(Quarterly Results - Dec 2025)
Net Profit:
76 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.3%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.63%
0%
-19.63%
6 Months
-32.68%
0%
-32.68%
1 Year
-19.03%
0.23%
-18.8%
2 Years
2.65%
1.85%
4.5%
3 Years
-11.21%
1.87%
-9.34%
4 Years
7.13%
2.51%
9.64%
5 Years
30.02%
3.40%
33.42%

Latest dividend: 1.2 per share ex-dividend date: Jul-25-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sumitomo Chemical India Ltd has declared 12% dividend, ex-date: 25 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
4.81%
EBIT Growth (5y)
7.50%
EBIT to Interest (avg)
93.70
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
1.33
Tax Ratio
25.48%
Dividend Payout Ratio
79.69%
Pledged Shares
0
Institutional Holding
12.03%
ROCE (avg)
32.87%
ROE (avg)
18.58%

Valuation key factors

Factor
Value
P/E Ratio
38
Industry P/E
39
Price to Book Value
6.39
EV to EBIT
32.76
EV to EBITDA
29.48
EV to Capital Employed
9.12
EV to Sales
5.98
PEG Ratio
6.99
Dividend Yield
0.29%
ROCE (Latest)
28.03%
ROE (Latest)
16.97%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 31 Schemes (6.53%)

FIIs

Held by 113 FIIs (3.37%)

Promoter with highest holding

Sumitomo Chemical Company Limited (75.0%)

Highest Public shareholder

Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver Fund (1.42%)

Individual Investors Holdings

9.8%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -38.92% vs -12.01% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -57.46% vs -0.32% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "567.98",
          "val2": "929.82",
          "chgp": "-38.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "99.49",
          "val2": "218.03",
          "chgp": "-54.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.02",
          "val2": "2.24",
          "chgp": "-9.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-16.11",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "75.63",
          "val2": "177.77",
          "chgp": "-57.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.52%",
          "val2": "23.45%",
          "chgp": "-5.93%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 8.72% vs 12.25% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 11.64% vs 55.50% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,986.59",
          "val2": "1,827.18",
          "chgp": "8.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "437.21",
          "val2": "406.37",
          "chgp": "7.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "2.41",
          "chgp": "61.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "356.10",
          "val2": "318.96",
          "chgp": "11.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.01%",
          "val2": "22.24%",
          "chgp": "-0.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 3.46% vs 13.80% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 6.36% vs 56.22% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,554.57",
          "val2": "2,469.10",
          "chgp": "3.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "536.70",
          "val2": "512.48",
          "chgp": "4.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.92",
          "val2": "4.20",
          "chgp": "40.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-16.11",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "431.73",
          "val2": "405.91",
          "chgp": "6.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.01%",
          "val2": "20.76%",
          "chgp": "0.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.71% vs -19.00% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 36.79% vs -26.42% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,148.52",
          "val2": "2,843.95",
          "chgp": "10.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "632.05",
          "val2": "474.58",
          "chgp": "33.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.86",
          "val2": "5.11",
          "chgp": "14.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "505.50",
          "val2": "369.54",
          "chgp": "36.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.07%",
          "val2": "16.69%",
          "chgp": "3.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
567.98
929.82
-38.92%
Operating Profit (PBDIT) excl Other Income
99.49
218.03
-54.37%
Interest
2.02
2.24
-9.82%
Exceptional Items
-16.11
0.00
Consolidate Net Profit
75.63
177.77
-57.46%
Operating Profit Margin (Excl OI)
17.52%
23.45%
-5.93%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -38.92% vs -12.01% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -57.46% vs -0.32% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
1,986.59
1,827.18
8.72%
Operating Profit (PBDIT) excl Other Income
437.21
406.37
7.59%
Interest
3.90
2.41
61.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
356.10
318.96
11.64%
Operating Profit Margin (Excl OI)
22.01%
22.24%
-0.23%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 8.72% vs 12.25% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 11.64% vs 55.50% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
2,554.57
2,469.10
3.46%
Operating Profit (PBDIT) excl Other Income
536.70
512.48
4.73%
Interest
5.92
4.20
40.95%
Exceptional Items
-16.11
0.00
Consolidate Net Profit
431.73
405.91
6.36%
Operating Profit Margin (Excl OI)
21.01%
20.76%
0.25%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 3.46% vs 13.80% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 6.36% vs 56.22% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
3,148.52
2,843.95
10.71%
Operating Profit (PBDIT) excl Other Income
632.05
474.58
33.18%
Interest
5.86
5.11
14.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
505.50
369.54
36.79%
Operating Profit Margin (Excl OI)
20.07%
16.69%
3.38%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 10.71% vs -19.00% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 36.79% vs -26.42% in Mar 2024

stock-summaryCompany CV
About Sumitomo Chemical India Ltd stock-summary
stock-summary
Sumitomo Chemical India Ltd
Small Cap
Pesticides & Agrochemicals
Sumitomo Chemical India Limited (SCIL) was incorporated originally on 15 February 2000 and converted from Private Limited to Public Limited w.e.f. 24th November 2018. SCIL is a subsidiary of Sumitomo Chemical Company Limited, Japan (SCCL). The Company is engaged in manufacturing of household insecticides, agricultural pesticides, public health insecticides and animal nutrition products.
Company Coordinates stock-summary
Icon
No Company Details Available